Views & Analysis Technology to optimise pharma talent management Making better and more cost-effective use of the workforce.
News Otsuka, Vera stake their claims to IgAN treatment Otsuka and Vera both have new phase 3 data on drugs for kidney disease IgA nephropathy, but can they make a mark in an increasingly crowded market?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
